This comprehensive report provides a detailed analysis of the global beef cattle vaccine market, projecting its growth trajectory from 2025 through 2032. The study examines key market drivers and trends across various product types, such as inactivated foot and mouth disease and Brucella vaccines, and applications including grass-fed and grain-fed cattle. Covering major regions like the Americas, APAC, and Europe, the research evaluates competitive landscapes, strategic company movements, and emerging opportunities among leading industry players.

Market Overview

Global Market Projections

The global Beef Cattle Vaccine market is projected to experience significant growth from 2025 through 2032, maintaining a steady compound annual growth rate throughout the forecast period.

Regional Market Projections

• United States: The market for Beef Cattle Vaccine in the United States is estimated to increase from 2025 through 2032, growing at a steady compound annual growth rate.
• China: The market for Beef Cattle Vaccine in China is estimated to increase from 2025 through 2032, growing at a steady compound annual growth rate.
• Europe: The market for Beef Cattle Vaccine in Europe is estimated to increase from 2025 through 2032, growing at a steady compound annual growth rate.

Report Scope and Methodology

Research Objectives

LPI (LP Information)'s newest research report, titled “Beef Cattle Vaccine Industry Forecast,” reviews total world Beef Cattle Vaccine sales in 2025. It provides a comprehensive analysis by region and market sector of projected Beef Cattle Vaccine sales for the period of 2026 through 2032. The report offers a detailed analysis in US$ millions of the world Beef Cattle Vaccine industry, with sales broken down by region, market sector, and sub-sector.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Beef Cattle Vaccine landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on:

• Beef Cattle Vaccine portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

This analysis is intended to provide a better understanding of these firms’ unique positions in an accelerating global Beef Cattle Vaccine market.

Market Drivers and Forecasting

The report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beef Cattle Vaccine. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Beef Cattle Vaccine market.

Overall, the report presents a comprehensive overview, market shares, and growth opportunities of the Beef Cattle Vaccine market by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Inactivated Foot and Mouth Disease Vaccine
• Bacillus Anthracis Vaccine
• Clostridium Botulinum Vaccine
• Brucella Vaccine
• Pasteurella Vaccine
• Bovine Rotavirus Vaccine
• Others

By Application

• Grass Fed Beef Cattle
• Grain-Fed Beef Cattle

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Share and Key Players

Global key Beef Cattle Vaccine players include Biogenesis Bagó, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, and CEVA, among others. In terms of revenue, the global two largest companies held a significant portion of the market share in 2025.

Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and analysis of the companies' coverage, product portfolios, and market penetration:

• Biogenesis Bagó
• Indian Immunologicals
• Boehringer Ingelheim
• MSD Animal Health
• CEVA
• Bayer HealthCare
• VECOL
• Brilliant Bio Pharma
• VETAL
• BVI
• LIMOR
• ME VAC
• Agrovet
• Zoetis
• Merck
• GlaxoSmithKline
• Serum Institute of India
• Elanco Animal Health
• Pharmgal Bio
• Creative Biolabs
• China Agricultural Veterinarian
• Yangling Jinhai
• China Animal Husbandry
• Tecon
• Bigvet
• Shen Lian
• Zhongpu
• The Spirit Jinyu

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Beef Cattle Vaccine Market Size (2021-2032)

    • 2.1.2 Beef Cattle Vaccine Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Beef Cattle Vaccine by Country/Region (2021, 2025 & 2032)

  • 2.2 Beef Cattle Vaccine Segment by Type

    • 2.2.1 Inactivated Foot and Mouth Disease Vaccine

    • 2.2.2 Bacillus Anthracis Vaccine

    • 2.2.3 Clostridium Botulinum Vaccine

    • 2.2.4 Brucella Vaccine

    • 2.2.5 Pasteurella Vaccine

    • 2.2.6 Bovine Rotavirus Vaccine

    • 2.2.7 Others

    • 2.2.8 Beef Cattle Vaccine Market Size by Type

      • 2.2.8.1 Beef Cattle Vaccine Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.8.2 Global Beef Cattle Vaccine Market Size Market Share by Type (2021-2026)

  • 2.3 Beef Cattle Vaccine Segment by Application

    • 2.3.1 Grass Fed Beef Cattle

    • 2.3.2 Grain-Fed Beef Cattle

    • 2.3.3 Beef Cattle Vaccine Market Size by Application

      • 2.3.3.1 Beef Cattle Vaccine Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.3.2 Global Beef Cattle Vaccine Market Size Market Share by Application (2021-2026)

• 3 Beef Cattle Vaccine Market Size by Player

  • 3.1 Beef Cattle Vaccine Market Size Market Share by Player

    • 3.1.1 Global Beef Cattle Vaccine Revenue by Player (2021-2026)

    • 3.1.2 Global Beef Cattle Vaccine Revenue Market Share by Player (2021-2026)

  • 3.2 Global Beef Cattle Vaccine Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Beef Cattle Vaccine by Region

  • 4.1 Beef Cattle Vaccine Market Size by Region (2021-2026)

  • 4.2 Global Beef Cattle Vaccine Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Beef Cattle Vaccine Market Size Growth (2021-2026)

  • 4.4 APAC Beef Cattle Vaccine Market Size Growth (2021-2026)

  • 4.5 Europe Beef Cattle Vaccine Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Beef Cattle Vaccine Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Beef Cattle Vaccine Market Size by Country (2021-2026)

  • 5.2 Americas Beef Cattle Vaccine Market Size by Type (2021-2026)

  • 5.3 Americas Beef Cattle Vaccine Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Beef Cattle Vaccine Market Size by Region (2021-2026)

  • 6.2 APAC Beef Cattle Vaccine Market Size by Type (2021-2026)

  • 6.3 APAC Beef Cattle Vaccine Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Beef Cattle Vaccine Market Size by Country (2021-2026)

  • 7.2 Europe Beef Cattle Vaccine Market Size by Type (2021-2026)

  • 7.3 Europe Beef Cattle Vaccine Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Beef Cattle Vaccine by Region (2021-2026)

  • 8.2 Middle East & Africa Beef Cattle Vaccine Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Beef Cattle Vaccine Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Beef Cattle Vaccine Market Forecast

  • 10.1 Global Beef Cattle Vaccine Forecast by Region (2027-2032)

    • 10.1.1 Global Beef Cattle Vaccine Forecast by Region (2027-2032)

    • 10.1.2 Americas Beef Cattle Vaccine Forecast

    • 10.1.3 APAC Beef Cattle Vaccine Forecast

    • 10.1.4 Europe Beef Cattle Vaccine Forecast

    • 10.1.5 Middle East & Africa Beef Cattle Vaccine Forecast

  • 10.2 Americas Beef Cattle Vaccine Forecast by Country (2027-2032)

    • 10.2.1 United States Market Beef Cattle Vaccine Forecast

    • 10.2.2 Canada Market Beef Cattle Vaccine Forecast

    • 10.2.3 Mexico Market Beef Cattle Vaccine Forecast

    • 10.2.4 Brazil Market Beef Cattle Vaccine Forecast

  • 10.3 APAC Beef Cattle Vaccine Forecast by Region (2027-2032)

    • 10.3.1 China Beef Cattle Vaccine Market Forecast

    • 10.3.2 Japan Market Beef Cattle Vaccine Forecast

    • 10.3.3 Korea Market Beef Cattle Vaccine Forecast

    • 10.3.4 Southeast Asia Market Beef Cattle Vaccine Forecast

    • 10.3.5 India Market Beef Cattle Vaccine Forecast

    • 10.3.6 Australia Market Beef Cattle Vaccine Forecast

  • 10.4 Europe Beef Cattle Vaccine Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Beef Cattle Vaccine Forecast

    • 10.4.2 France Market Beef Cattle Vaccine Forecast

    • 10.4.3 UK Market Beef Cattle Vaccine Forecast

    • 10.4.4 Italy Market Beef Cattle Vaccine Forecast

    • 10.4.5 Russia Market Beef Cattle Vaccine Forecast

  • 10.5 Middle East & Africa Beef Cattle Vaccine Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Beef Cattle Vaccine Forecast

    • 10.5.2 South Africa Market Beef Cattle Vaccine Forecast

    • 10.5.3 Israel Market Beef Cattle Vaccine Forecast

    • 10.5.4 Turkey Market Beef Cattle Vaccine Forecast

  • 10.6 Global Beef Cattle Vaccine Forecast by Type (2027-2032)

  • 10.7 Global Beef Cattle Vaccine Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Beef Cattle Vaccine Forecast

• 11 Key Players Analysis

  • 11.1 Biogenesis Bagó

    • 11.1.1 Biogenesis Bagó Company Information

    • 11.1.2 Biogenesis Bagó Beef Cattle Vaccine Product Offered

    • 11.1.3 Biogenesis Bagó Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Biogenesis Bagó Main Business Overview

    • 11.1.5 Biogenesis Bagó Latest Developments

  • 11.2 Indian Immunologicals

    • 11.2.1 Indian Immunologicals Company Information

    • 11.2.2 Indian Immunologicals Beef Cattle Vaccine Product Offered

    • 11.2.3 Indian Immunologicals Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Indian Immunologicals Main Business Overview

    • 11.2.5 Indian Immunologicals Latest Developments

  • 11.3 Boehringer Ingelheim

    • 11.3.1 Boehringer Ingelheim Company Information

    • 11.3.2 Boehringer Ingelheim Beef Cattle Vaccine Product Offered

    • 11.3.3 Boehringer Ingelheim Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Boehringer Ingelheim Main Business Overview

    • 11.3.5 Boehringer Ingelheim Latest Developments

  • 11.4 MSD Animal Health

    • 11.4.1 MSD Animal Health Company Information

    • 11.4.2 MSD Animal Health Beef Cattle Vaccine Product Offered

    • 11.4.3 MSD Animal Health Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 MSD Animal Health Main Business Overview

    • 11.4.5 MSD Animal Health Latest Developments

  • 11.5 CEVA

    • 11.5.1 CEVA Company Information

    • 11.5.2 CEVA Beef Cattle Vaccine Product Offered

    • 11.5.3 CEVA Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 CEVA Main Business Overview

    • 11.5.5 CEVA Latest Developments

  • 11.6 Bayer HealthCare

    • 11.6.1 Bayer HealthCare Company Information

    • 11.6.2 Bayer HealthCare Beef Cattle Vaccine Product Offered

    • 11.6.3 Bayer HealthCare Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Bayer HealthCare Main Business Overview

    • 11.6.5 Bayer HealthCare Latest Developments

  • 11.7 VECOL

    • 11.7.1 VECOL Company Information

    • 11.7.2 VECOL Beef Cattle Vaccine Product Offered

    • 11.7.3 VECOL Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 VECOL Main Business Overview

    • 11.7.5 VECOL Latest Developments

  • 11.8 Brilliant Bio Pharma

    • 11.8.1 Brilliant Bio Pharma Company Information

    • 11.8.2 Brilliant Bio Pharma Beef Cattle Vaccine Product Offered

    • 11.8.3 Brilliant Bio Pharma Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Brilliant Bio Pharma Main Business Overview

    • 11.8.5 Brilliant Bio Pharma Latest Developments

  • 11.9 VETAL

    • 11.9.1 VETAL Company Information

    • 11.9.2 VETAL Beef Cattle Vaccine Product Offered

    • 11.9.3 VETAL Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 VETAL Main Business Overview

    • 11.9.5 VETAL Latest Developments

  • 11.10 BVI

    • 11.10.1 BVI Company Information

    • 11.10.2 BVI Beef Cattle Vaccine Product Offered

    • 11.10.3 BVI Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 BVI Main Business Overview

    • 11.10.5 BVI Latest Developments

  • 11.11 LIMOR

    • 11.11.1 LIMOR Company Information

    • 11.11.2 LIMOR Beef Cattle Vaccine Product Offered

    • 11.11.3 LIMOR Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 LIMOR Main Business Overview

    • 11.11.5 LIMOR Latest Developments

  • 11.12 ME VAC

    • 11.12.1 ME VAC Company Information

    • 11.12.2 ME VAC Beef Cattle Vaccine Product Offered

    • 11.12.3 ME VAC Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 ME VAC Main Business Overview

    • 11.12.5 ME VAC Latest Developments

  • 11.13 Agrovet

    • 11.13.1 Agrovet Company Information

    • 11.13.2 Agrovet Beef Cattle Vaccine Product Offered

    • 11.13.3 Agrovet Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Agrovet Main Business Overview

    • 11.13.5 Agrovet Latest Developments

  • 11.14 Zoetis

    • 11.14.1 Zoetis Company Information

    • 11.14.2 Zoetis Beef Cattle Vaccine Product Offered

    • 11.14.3 Zoetis Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Zoetis Main Business Overview

    • 11.14.5 Zoetis Latest Developments

  • 11.15 Merck

    • 11.15.1 Merck Company Information

    • 11.15.2 Merck Beef Cattle Vaccine Product Offered

    • 11.15.3 Merck Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Merck Main Business Overview

    • 11.15.5 Merck Latest Developments

  • 11.16 GlaxoSmithKline

    • 11.16.1 GlaxoSmithKline Company Information

    • 11.16.2 GlaxoSmithKline Beef Cattle Vaccine Product Offered

    • 11.16.3 GlaxoSmithKline Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 GlaxoSmithKline Main Business Overview

    • 11.16.5 GlaxoSmithKline Latest Developments

  • 11.17 Serum Institute of India

    • 11.17.1 Serum Institute of India Company Information

    • 11.17.2 Serum Institute of India Beef Cattle Vaccine Product Offered

    • 11.17.3 Serum Institute of India Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Serum Institute of India Main Business Overview

    • 11.17.5 Serum Institute of India Latest Developments

  • 11.18 Elanco Animal Health

    • 11.18.1 Elanco Animal Health Company Information

    • 11.18.2 Elanco Animal Health Beef Cattle Vaccine Product Offered

    • 11.18.3 Elanco Animal Health Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 Elanco Animal Health Main Business Overview

    • 11.18.5 Elanco Animal Health Latest Developments

  • 11.19 Pharmgal Bio

    • 11.19.1 Pharmgal Bio Company Information

    • 11.19.2 Pharmgal Bio Beef Cattle Vaccine Product Offered

    • 11.19.3 Pharmgal Bio Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 Pharmgal Bio Main Business Overview

    • 11.19.5 Pharmgal Bio Latest Developments

  • 11.20 Creative Biolabs

    • 11.20.1 Creative Biolabs Company Information

    • 11.20.2 Creative Biolabs Beef Cattle Vaccine Product Offered

    • 11.20.3 Creative Biolabs Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.20.4 Creative Biolabs Main Business Overview

    • 11.20.5 Creative Biolabs Latest Developments

  • 11.21 China Agricultural Veterinarian

    • 11.21.1 China Agricultural Veterinarian Company Information

    • 11.21.2 China Agricultural Veterinarian Beef Cattle Vaccine Product Offered

    • 11.21.3 China Agricultural Veterinarian Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.21.4 China Agricultural Veterinarian Main Business Overview

    • 11.21.5 China Agricultural Veterinarian Latest Developments

  • 11.22 Yangling Jinhai

    • 11.22.1 Yangling Jinhai Company Information

    • 11.22.2 Yangling Jinhai Beef Cattle Vaccine Product Offered

    • 11.22.3 Yangling Jinhai Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.22.4 Yangling Jinhai Main Business Overview

    • 11.22.5 Yangling Jinhai Latest Developments

  • 11.23 China Animal Husbandry

    • 11.23.1 China Animal Husbandry Company Information

    • 11.23.2 China Animal Husbandry Beef Cattle Vaccine Product Offered

    • 11.23.3 China Animal Husbandry Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.23.4 China Animal Husbandry Main Business Overview

    • 11.23.5 China Animal Husbandry Latest Developments

  • 11.24 Tecon

    • 11.24.1 Tecon Company Information

    • 11.24.2 Tecon Beef Cattle Vaccine Product Offered

    • 11.24.3 Tecon Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.24.4 Tecon Main Business Overview

    • 11.24.5 Tecon Latest Developments

  • 11.25 Bigvet

    • 11.25.1 Bigvet Company Information

    • 11.25.2 Bigvet Beef Cattle Vaccine Product Offered

    • 11.25.3 Bigvet Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.25.4 Bigvet Main Business Overview

    • 11.25.5 Bigvet Latest Developments

  • 11.26 Shen Lian

    • 11.26.1 Shen Lian Company Information

    • 11.26.2 Shen Lian Beef Cattle Vaccine Product Offered

    • 11.26.3 Shen Lian Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.26.4 Shen Lian Main Business Overview

    • 11.26.5 Shen Lian Latest Developments

  • 11.27 Zhongpu

    • 11.27.1 Zhongpu Company Information

    • 11.27.2 Zhongpu Beef Cattle Vaccine Product Offered

    • 11.27.3 Zhongpu Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.27.4 Zhongpu Main Business Overview

    • 11.27.5 Zhongpu Latest Developments

  • 11.28 The Spirit Jinyu

    • 11.28.1 The Spirit Jinyu Company Information

    • 11.28.2 The Spirit Jinyu Beef Cattle Vaccine Product Offered

    • 11.28.3 The Spirit Jinyu Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2021-2026)

    • 11.28.4 The Spirit Jinyu Main Business Overview

    • 11.28.5 The Spirit Jinyu Latest Developments

• 12 Research Findings and Conclusion